Aroa Biosurgery Limited (ASX:ARX) Annual Report 2021



The latest annual report of Aroa Biosurgery Limited (ARX) was published on 31 Mar 2021. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - ARX Annual Results

Amounts in NZD

Total Revenue
22.34M
Gross Profit
15.52M
EBIT
-9.98M
Net Tangible Assets
40.41M
Net Income
-19.21M
Capital Expenditures
-1.26M

ARX Income Statement 2021 Annual Report

As per the latest Income Statement of ARX, the Net revenue decreased by $-2.73M (-11%) compared to the previous period. The operating income in 2021 decreased by $-7.13M (-251%). The net income as per the annual report was -19.21M which decreased by $-13.25M (-222%) compared to previous year.

Income Statement Report (2021/2020)

20212020
Total Revenue22.34M25.08M
Gross Profit15.52M18.74M
Operating Income-9.98M-2.84M
Income Before Tax-19.1M-6.16M
Net Income-19.21M-5.96M

Balance Sheet - ARX 2021 Annual Report

Read further: ARX Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Aroa Biosurgery Limited showed the company increased the cash on balance sheet by $11.53M (300%). The Net tangible assets of ARX on the balance sheet were at 40.41M which is $51.86M (453%) more than previous annual report. The total stockholder equity also increased by $50.88M (669%) compared to previous reporting period.

Balance Sheet Statement Report (2021/2020)

20212020
Cash15.38M3.85M
Total Assets79.66M 45.96M
Long Term Debt-1.12M
Total Liabilities21.17M 38.36M
Total Shareholder Equity58.49M7.61M
Net Tangible Assets40.41M-11.45M

Cash Flow Statement - ARX 2021 Annual Report

The 2021 annual cash flow statement of Aroa Biosurgery Limited showed that the net income decreased by $-13.25M (-222%) compared to previous reporting period. Also the capital expenditure of ARX increased by $426000 (25%).

As of 2021, the total cash from investing activities was -21.5M and total cash from financing activities was 37.1M.

Cash Flow Statement Report (2021/2020)

20212020
Net Income-19.21M-5.96M
Capital Expenditures-1.26M-1.69M
Dividends Paid--
Total Cash From From Investing Activities-21.5M-1.87M
Total Cash From From Financing Activities37.1M-384k

Aroa Biosurgery Limited Annual Report History

Income Statement

Income Statement history of Aroa Biosurgery Limited (ASX:ARX)

31 Mar 202131 Mar 202031 Mar 201931 Mar 2018
Total Revenue22.34M25.08M24.19M11.1M
Cost Of Revenue6.82M6.34M7M5.63M
Gross Profit15.52M18.74M17.19M5.47M
Research Development6.42M5.04M4.64M3.35M
Selling General Administrative21.76M16.67M11.86M3.9M
Non Recurring----
Other Operating Expenses-2.68M-131k-189k-109k
Total Operating Expenses32.32M27.92M23.31M12.77M
Operating Income-9.98M-2.84M876k-1.67M
Total Other Income Expense Net-9.12M-3.32M-3.92M87k
Ebit-9.98M-2.84M876k-1.67M
Interest Expense-1.91M-2.97M-2.67M-68k
Income Before Tax-19.1M-6.16M-3.05M-1.58M
Income Tax Expense107k-202k-4.01M-308k
Minority Interest----
Net Income From Continuing Ops-19.21M-5.96M960k-1.28M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income-19.21M-5.96M960k-1.28M
Net Income Applicable To Common Shares-19.21M-5.96M960k-1.28M

Balance Sheet Statement

Balance Sheet Statement history of Aroa Biosurgery Limited (ASX:ARX)

31 Mar 202131 Mar 202031 Mar 201931 Mar 2018
Cash15.38M3.85M4.46M3.88M
Short Term Investments21.58M969k--
Net Receivables7.23M7.39M5.47M2.64M
Inventory3.61M4M2.68M1.79M
Other Current Assets31k1.19M10k-
Total Current Assets48.75M17.98M13.15M9.46M
Property Plant Equipment12.66M8.73M6.09M5.42M
Good Will5.54M5.54M5.54M-
Intangible Assets12.54M13.52M14.55M335k
Other Assets171k193k216k-
Total Assets79.66M45.96M39.54M15.21M
Accounts Payable740k1.2M454k717k
Short Long Term Debt9.95M22.52M5.07M132k
Other Current Liab27k7.24M363k737k
Other Liab161k158k154k9.54M
Total Current Liabilities15.29M35.21M8.15M2.39M
Total Liab21.17M38.36M27.54M13.33M
Common Stock97.32M29.35M28.89M19.91M
Retained Earnings-42.74M-23.53M-17.59M-18.54M
Treasury Stock3.91M1.79M702k500k
Other Stockholder Equity3.91M1.79M702k500k
Total Stockholder Equity58.49M7.61M12M1.88M
Net Tangible Assets40.41M-11.45M-8.08M1.54M
Long Term Debt-1.12M19.23M1.39M

Cash Flow Statement

Cash Flow Statement history of Aroa Biosurgery Limited (ASX:ARX)

31 Mar 202131 Mar 202031 Mar 201931 Mar 2018
Net Income-19.21M-5.96M960k-1.28M
Depreciation3.05M2.72M2.06M732k
Change To Netincome10.12M6.01M-392k-524k
Change To Account Receivables-489k-1.68M-2.66M-1.63M
Change To Liabilities-298k2.27M730k256k
Change To Inventory632k-1.33M-889k-500k
Change To Operating Activities-826k-26k-83k22k
Total Cash From Operating Activities-5.01M1.66M-7k-3.04M
Capital Expenditures-1.26M-1.69M-1.56M-1.57M
Investments-20M-20M-20M7M
Total Cashflows From Investing Activities-21.5M-1.87M-3.71M5.32M
Net Borrowings-12.92M-6.1M-4.73M396k
Other Cashflows From Financing Activities15.07M5.42M5.42M5.42M
Total Cash From Financing Activities37.1M-384k4.13M444k
Effect Of Exchange Rate939k-13k156k80k
Change In Cash11.53M-607k579k2.81M
Issuance Of Stock34.95M296k8.87M48k
Dividends Paid----